Date: November 12-15, 2003
Location: New York, New York
The content presented here was prepared by independent authors under the editorial supervision of OncoEd and is not endorsed or sanctioned by the Chemotherapy Foundation Symposium XXI.
Conference Summaries
An Update from the Chemotherapy Foundation on Non-Small Cell Lung Cancer
Lung cancer is the number one cause of cancer-related deaths in the United States and in women, this malignancy has overtaken heart disease as the number one killer. Non-small cell lung cancer (NSCLC) accounts for 80 to 85% of all lung cancer cases and approximately one-third of NSCLC patients present with advanced disease.
Chemotherapy for Advanced Ovarian Cancer: Past, Present and Future
During the ovarian cancer session of the 21st Chemotherapy Foundation Symposium, an update on standard and emerging treatments for patients with advanced ovarian cancer was presented.
Patient Home
2009 Coverage
